Looking to history to prepare for America’s uncertain future
Manage episode 450993434 series 3079777
Since the results of the US election, the news has been awash with what the future might hold under a second Trump Administration, particularly within healthcare and life sciences.
In today’s podcast, web editor Nicole Raleigh is joined by Jesse Mendelsohn, senior vice president of Model N’s Center of Excellence, for a conversation that explores multiple aspects of the drug pricing debate in America – speaking before President-Elect Donald Trump confirmed his nomination of Robert F Kennedy Jr as US Health and Human Services Secretary.
Mendelsohn – using history as a guide – suggests there will be a layering of new laws, with, for example, a push for changes to the Inflation Reduction Act, rather than repeal of it. And he explores the potential impacts on pharma, also.
219 episoder